Journal article
Transcatheter aortic valve implantation in patients with bicuspid aortic valve: A patient level multi-center analysis
Abstract
OBJECTIVE: We sought to evaluate the safety and efficacy of transcatheter aortic valve implantation (TAVI) in patients with bicuspid aortic valve (BiAV).
BACKGROUND: BiAV remains a relative contraindication to TAVI resulting in exclusion from TAVI trials and thus limiting data on the clinical performance of transcatheter valves in these patients.
Authors
Yousef A; Simard T; Webb J; Rodés-Cabau J; Costopoulos C; Kochman J; Hernández-Garcia JM; Chiam PTL; Welsh RC; Wijeysundera HC
Journal
International Journal of Cardiology, Vol. 189, , pp. 282–288
Publisher
Elsevier
Publication Date
June 2015
DOI
10.1016/j.ijcard.2015.04.066
ISSN
0167-5273
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
AdultAge FactorsAgedAortic ValveAortic Valve StenosisBicuspid Aortic Valve DiseaseChi-Square DistributionEchocardiography, TransesophagealFemaleFollow-Up StudiesHeart Valve DiseasesHeart Valve ProsthesisHumansMaleMiddle AgedPatient SafetyRisk AssessmentSex FactorsSurvival AnalysisTime FactorsTranscatheter Aortic Valve ReplacementTreatment Outcome